This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Centene is now a $100-billion plus enterprise catering healthcare services to more than 24 million members across 50 states. The recent acquisition of WellCare Health leveraged the company’s position as the largest Medicaid managed care organization in the country. The combined entity now has 22 million members. In 2019, the company retained its market-leading position nationwide, serving 1.8 million exchange members across 20 states at the year-end.
MEDNAX's (MD) Earnings Beat Estimates in Q2, Decrease Y/Y
by Zacks Equity Research
Mednax's (MD) Q2 gains on revenue growth, partly offset by rise in expenses.
6 Promising Price-to-Book Value Stocks to Buy in August
by Kinjel Shah
P/B ratio is emerging as a convenient tool for identifying low-priced stocks that have high growth prospects.
Humana's (HUM) Earnings and Revenues Beat Estimates in Q2
by Zacks Equity Research
Humana's (HUM) second-quarter earnings gain from Medicare Advantage membership growth.
Molina Healthcare (MOH) Q2 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) second-quarter earnings trump estimates on the back of lower expenses and the Meridian buyout.
WellCare Health (WCG) Q2 Earnings & Revenues Beat, Rise Y/Y
by Zacks Equity Research
WellCare Health's (WCG) second-quarter earnings gain from improved revenues and higher membership.
HCA Healthcare (HCA) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
HCA Healthcare's (HCA) second-quarter earnings decline due to escalating expenses.
Universal Health's (UHS) Q2 Earnings Top Estimates, Rise Y/Y
by Zacks Equity Research
Universal Health's (UHS) second-quarter results gain from its healthy top-line growth.
Should Value Investors Buy Centene (CNC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
3 Reasons Why Centene (CNC) Is a Great Growth Stock
by Zacks Equity Research
Centene (CNC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Centene's (CNC) Q2 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
Centene's (CNC) second-quarter earnings benefit from higher revenues and operational efficiency.
Centene (CNC) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Centene (CNC) delivered earnings and revenue surprises of 8.06% and 1.94%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Centene (CNC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Centene (CNC) closed the most recent trading day at $53.10, moving -0.24% from the previous trading session.
Is a Beat in the Cards for Centene's (CNC) Q2 Earnings?
by Zacks Equity Research
Centene's (CNC) Q2 earnings are likely to be cushioned by higher revenues and membership.
Centene (CNC) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Centene (CNC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
UnitedHealth (UNH) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
UnitedHealth's (UNH) second-quarter results are expected to be boosted by the revenue growth at UnitedHealthcare and Optum segments and increasing membership.
Trump Drops Drug Rebate Proposal: What's Next and What Stocks to Play
by Christopher Vargas
The Trump administration announced Thursday that it's deciding to withdraw its proposal to eliminate rebates from government drug plans.
Centene (CNC) Acquires Additional Stake in Ribera Salud
by Zacks Equity Research
Centene (CNC) buys a surplus share in Ribera Salud to fortify its footprint in Europe.
3 Healthcare Stocks to Stay on Your Watch List for 2H19
by Zacks Equity Research
Banking on Medicaid and Medicare business, these three stocks should remain in your focus for the second half of 2019.
Why Centene (CNC) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Centene (CNC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Magellan Health Mulls Over Possible Sale to Centerbridge
by Zacks Equity Research
Magellan Health (MGLN) in talks for a possible sale to Centerbridge after its subdued performance.
Centene (CNC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Centene (CNC) closed at $52.45, marking a +0.83% move from the previous day.
The Zacks Analyst Blog Highlights: Caterpillar, Royal Dutch, Goldman, Barrick and Centene
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Caterpillar, Royal Dutch, Goldman, Barrick and Centene
Top Research Reports for Caterpillar, Royal Dutch Shell & Goldman Sachs
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Caterpillar (CAT), Royal Dutch Shell (RDS.A) and Goldman Sachs (GS).
Centene (CNC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Centene (CNC) closed the most recent trading day at $55.46, moving +0.36% from the previous trading session.
Centene (CNC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Centene (CNC) closed the most recent trading day at $53.78, moving +0.17% from the previous trading session.